Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
We examine the clinical significance and biomarkers of tissue plasminogen activator (tPA)-catalyzed clot lysis time (CLT) in patients with intermediate-risk pulmonary embolism (PE).Platelet-poor, citrated plasma was obtained from patients with PE. Healthy age- and sex-matched patients served as dise...
Main Authors: | William B Stubblefield, Nathan J Alves, Matthew T Rondina, Jeffrey A Kline |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4751085?pdf=render |
Similar Items
-
Comment on “Fibrinolysis for patients with intermediate-risk pulmonary embolism”
by: Maria da Graça Castro
Published: (2014-10-01) -
Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01) -
Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01) -
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.
by: Fatma Berri, et al.
Published: (2013-03-01) -
Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis
by: Hong Wang, et al.
Published: (2016-11-01)